Incannex Healthcare Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity

Consolidated Statements of Stockholders’ Equity (Deficit)

(in thousands, except share amounts)

Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit)
	Share	Amount	Amount	Amount	Amount	Amount
	#	$	$	$	$	$
Balance at June 30, 2023	15,873,113	2	116,290	(92,212)	(3,255)	20,825
Options exercised
Options issued to advisors
Option placements
Share-based compensation			5,714			5,714
Share placements
Share issued to advisors
Asset acquisition shares issued
Issuance costs
Net loss				(11,998)		(11,998)
Currency translation adjustment, net of tax					(403)	(403)
Balance at March 31, 2024	15,873,113	2	122,004	(104,210)	(3,658)	14,138

Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit)
	Share	Amount	Amount	Amount	Amount	Amount
	#	$	$	$	$	$
Balance at June 30, 2022	12,926,349	1	69,074	(43,401)	(963)	24,711
Options exercised	21
Options issued to advisors			476			476
Option placements
Share-based compensation			1,631			1,631
Share placements	634,146		8,830			8,830
Share issued to advisors	130,902		2,050			2,050
Asset acquisition shares issued	2,181,695	1	34,170			34,171
Issuance costs			(531)			(531)
Net loss				(44,637)		(44,637)
Currency translation adjustment, net of tax					(2,029)	(2,029)
Balance at March 31, 2023	15,873,113	2	115,700	(88,038)	(2,992)	24,672

Consolidated Statements of Stockholders’ Equity (Deficit) (Continued)

(in thousands, except share amounts)

Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit)
	Share	Amount	Amount	Amount	Amount	Amount
	#	$	$	$	$	$
Balance at January 1, 2024	15,873,113	2	119,887	(98,179)	(2,838)	18,872
Options exercised
Options issued to advisors
Option placements
Share-based compensation			2,117			2,117
Share placements
Share issued to advisors
Asset acquisition shares issued
Issuance costs
Net loss				(6,031)		(6,031)
Currency translation adjustment, net of tax					(820)	(820)
Balance at March 31, 2024	15,873,113	2	122,004	(104,210)	(3,658)	14,138

Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit)
	Share	Amount	Amount	Amount	Amount	Amount
	#	$	$	$	$	$
Balance at January 1, 2023	15,873,092	2	115,169	(84,467)	(2,790)	27,913
Options exercised	21
Options issued to advisors
Option placements
Share-based compensation			531			531
Share placements
Share issued to advisors
Asset acquisition shares issued
Issuance costs
Net loss				(3,571)		(3,571)
Currency translation adjustment, net of tax					(202)	(202)
Balance at March 31, 2023	15,873,113	2	115,700	(88,038)	(2,992)	24,672

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.